Access restrictions apply.Some or all content stored offsite.
Container | Contents | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Part II: Subject File, 1902-2012 (continued) | |||||||||||||
BOX II:182 | Neonatal pharmacology, 1960-1982, undated | ||||||||||||
(2 folders) | |||||||||||||
BOX II:182 | Nester, John O., circa 1992-2000 | ||||||||||||
BOX II:183 | New Drug Application (NDA) Preservation Committee | ||||||||||||
BOX II:183 | General, 1962-1964, 1982, 1992-2001, undated | ||||||||||||
BOX II:183 | Lists of NDAs reviewed by Kelsey, undated | ||||||||||||
BOX II:183 | Lists of NDAs (1938-1948) to be transferred to National Archives, Washington, D.C., 1995-1996 | ||||||||||||
BOX II:183 | Printout of NDAs approved from 1949, Jan. 1 to 1956, Dec. 31, 1995 | ||||||||||||
BOX II:183 | New Drug Evaluation Office, U.S. Food and Drug Administration | ||||||||||||
BOX II:183 | Associate director, 1977-1982, 2001 | ||||||||||||
(2 folders) | |||||||||||||
BOX II:184 | Committee to Update the Management Information System, 1982-1983 | ||||||||||||
BOX II:184 | Deputy associate director, 1980-1982 | ||||||||||||
BOX II:184 | General, 1976-1983 | ||||||||||||
BOX II:184 | Minutes of division director meetings, 1980-1984 | ||||||||||||
(2 folders) | |||||||||||||
BOX II:184 | Project Management Systems, implementation session, 1980 | ||||||||||||
BOX II:184 | New uses for approved drugs See Container II:208, “Use of Drugs for Unapproved Indications: Your Legal Responsibility” | ||||||||||||
BOX II:184 | Nishimura, Hideo | ||||||||||||
BOX II:184 | General, 1966-1969, 1976, 1996-2000 | ||||||||||||
BOX II:184 | Writings, 1968-1975, 1983 | ||||||||||||
BOX II:184 | Nurses’ responsibilities in clinical investigations, undated | ||||||||||||
BOX II:184 | Nutritional aspects, 1968-1974, 1981, undated | ||||||||||||
BOX II:185 | Office of Planning Evaluation, studies, 1978-1981, 1993 | ||||||||||||
(4 folders) | |||||||||||||
BOX II:185 | Omeprazole, 1989-1990, undated | ||||||||||||
BOX II:185 | Organizational Effectiveness Project, 1970, 1981-1982, undated | ||||||||||||
(2 folders) | |||||||||||||
BOX II:185 | Orphan drugs, 1973, 1982-1983, 1992, 1998, undated | ||||||||||||
BOX II:186 | Oxsoralen (methoxsalen), 1992-1993 | ||||||||||||
BOX II:186 | Pediatric labeling rule, draft, 1997 | ||||||||||||
BOX II:186 | PEG-Superoxide Dimutase (PEG-SOD), 1993 | ||||||||||||
BOX II:186 | Penicillamine, 1969-1971, 1983-1984, undated | ||||||||||||
BOX II:186 | Pentamidine, 1982-1987, 1996, undated | ||||||||||||
BOX II:186 | Pesticides and environmental hazards, 1950-1984, 1996-1998, undated | ||||||||||||
(4 folders) | |||||||||||||
BOX II:186 | Phase I trials, 1976-1982 | ||||||||||||
BOX II:186 | Phenacetin, 1961-1962, 1980, 1996 | ||||||||||||
BOX II:186 | Phenformin, 1979-1980 | ||||||||||||
BOX II:187 | Placebos, 1950-2000 | ||||||||||||
(2 folders) | |||||||||||||
BOX II:187 | Placental transmission of drugs, 1962-1973, 1979, undated | ||||||||||||
BOX II:187 | Podophyllin, drug deformities, 1962-1963, 1972, 1984 | ||||||||||||
BOX II:187 | Poisonous plants and animals, 1955, 1961-2002, undated | ||||||||||||
(3 folders) | |||||||||||||
BOX II:187 | Poquil, 1953-1956 | ||||||||||||
BOX II:187 | Practolol, 1975, 1996 | ||||||||||||
BOX II:187 | Prednisolone, 1968, 1997 | ||||||||||||
BOX II:187 | Pregnancy and drug metabolism, 1965-1977, circa 1982, undated | ||||||||||||
BOX II:188 | Pregnancy labeling, 1966-1969, 1975-1983, 1997-2001 | ||||||||||||
BOX II:188 | Preludin, drug deformities, 1962, 1973 | ||||||||||||
BOX II:188 | Primidone See Containers II:128-II:129, Diphenylhydantoin | ||||||||||||
BOX II:188 | Prison studies/testing, 1968-1983, 1991, 1999-2000 | ||||||||||||
(4 folders) | |||||||||||||
BOX II:188 | Privacy Act/Confidentiality statute | ||||||||||||
BOX II:188 | Bioresearch monitoring, 1974-1984 | ||||||||||||
BOX II:188 | Statutory protection for medical records, 1977 | ||||||||||||
BOX II:189 | Task Force on Health and Medical Records, 1974-1977 | ||||||||||||
BOX II:189 | Procaine with polyvinylpyrrolidone (PVP) | ||||||||||||
BOX II:189 | General, 1968-1987, 1995-2000, undated | ||||||||||||
BOX II:189 | Testimony of Kelsey, 1979 | ||||||||||||
BOX II:189 | Progestin and other sex steroids, 1942, 1950-2000, undated | ||||||||||||
(4 folders) | |||||||||||||
BOX II:189 | Prolactin See Container II:116, Bromocryptine | ||||||||||||
BOX II:189 | Proprandol See Container II:98, Antihypertensives | ||||||||||||
BOX II:189 | Propulsid, 2000-2001 | ||||||||||||
BOX II:189 | Prostaglandins, 1970-1973, 1984-1985, undated | ||||||||||||
BOX II:190 | Pruzansky, Samuel, 1954-1960, 1967-1969 | ||||||||||||
BOX II:190 | Psychotropic drugs, 1962-1984, 1993-2002, undated | ||||||||||||
BOX II:190 | Public Employees Roundtable, photographic slides, 1984 | ||||||||||||
BOX II:190 | Quaaludes, 1972-1980, 1996 | ||||||||||||
BOX II:190 | Quackery, 1962-1965, 1975, 1989-1999, undated | ||||||||||||
BOX II:190 | Quinine and quinine drugs, 1954-1956, 1964-1972, 1978-1991, 1996-1999 | ||||||||||||
BOX II:190 | Radiation, 1929, 1962-1999, undated | ||||||||||||
(3 folders) | |||||||||||||
BOX II:190 | Radioactive Drug Research Committees See Container II:134, same heading | ||||||||||||
BOX II:191 | Ratner, Herbert, 1962, 1968, 1996-1999 | ||||||||||||
BOX II:191 | Regulatory Affairs Professionals Society, 1980, 1990-1997 | ||||||||||||
BOX II:191 | Research Testing Laboratories, Inc., Great Neck, N.Y., transcript of conference, 1993 | ||||||||||||
BOX II:191 | Retinoids See Containers II:208-II:209, Vitamin D and Vitamin A | ||||||||||||
BOX II:191 | Review Panel on New Drug Regulation, final report, 1977 | ||||||||||||
BOX II:191 | Reye’s syndrome See same container, Salicylates | ||||||||||||
BOX II:191 | Rezulin See Container II:156, Hypoglycemic oral agents | ||||||||||||
BOX II:191 | Rounds, 1972-1981, undated | ||||||||||||
BOX II:191 | Royal Society of Medicine, London, England, 1965-1969, 1989, 1996-1999 | ||||||||||||
BOX II:191 | Salicylates, 1959-1985, undated | ||||||||||||
BOX II:191 | Schering Corp. See Container II:142, Flunixin | ||||||||||||
BOX II:191 | Schiffirin, M. J., 1965, 1973, 1984, 1998 | ||||||||||||
BOX II:191 | Selenium See Container II:206, Toxicology | ||||||||||||
BOX II:191 | Semustine See Containers II:180-II:182, National Cancer Institute | ||||||||||||
BOX II:191 | Separation of functions, 1980 | ||||||||||||
BOX II:191 | Serc (Drug), 1968-1969, 1996, undated | ||||||||||||
BOX II:191 | Serotonin, 1963-1964, 1970, undated | ||||||||||||
BOX II:191 | Shepard, Thomas H., Compendium of Teratogens, 1971, 1996 | ||||||||||||
BOX II:192 | Shopsin, Baron, 1991 | ||||||||||||
BOX II:192 | Sigma Xi, The Scientific Research Society, U.S. Food and Drug Administration club, 1982-1987, 1996-1997, 2012 | ||||||||||||
BOX II:192 | Sjoerdsma, Albert, honorary banquet for, 1989 | ||||||||||||
BOX II:192 | Society of Nuclear Medicine, 1960-1973, 1998, undated | ||||||||||||
BOX II:192 | Society of Toxicology, 1964, undated | ||||||||||||
BOX II:192 | Special Survey: Sponsors and Investigators of Clinical Investigations, report on | ||||||||||||
BOX II:192 | 1970-1980 | ||||||||||||
(6 folders) | |||||||||||||
BOX II:192 | Undated | ||||||||||||
(1 folder) | |||||||||||||
BOX II:193 | (1 folder) | ||||||||||||
BOX II:193 | Spermacides/trichamonacides, 1972-1986 | ||||||||||||
BOX II:193 | Staff College Executive Committee, 1989-1990 | ||||||||||||
BOX II:193 | Stem cells, 2000-2001 | ||||||||||||
BOX II:193 | Stolpen, Adam, “Allergic Drug Reactions: Where Does the Duty Lie?” circa 1970, 1997 | ||||||||||||
BOX II:193 | Straus, Marc J., 1980-1982, 1996-1997, undated | ||||||||||||
(4 folders) | |||||||||||||
BOX II:193 | Submission management and review tracking, 1995 | ||||||||||||
BOX II:193 | Summers, William K., 1987-1989, 1997-1999, undated | ||||||||||||
BOX II:193 | Supplements, memoranda by Kelsey, 1968 | ||||||||||||
BOX II:194 | Suprofen, 1987 | ||||||||||||
BOX II:194 | Tamoxifen, report, 1997 | ||||||||||||
BOX II:194 | Taussig, Helen B., 1977, 1988, 1994, 2001, undated | ||||||||||||
BOX II:194 | Teplick, Steven K., hearing at U.S. Food and Drug Administration, 1993-1999 | ||||||||||||
BOX II:194 | Teratology | ||||||||||||
BOX II:194 | General, 1946, 1960-1962, 1968-1997, undated | ||||||||||||
(2 folders) | |||||||||||||
BOX II:194 | Screening procedures | ||||||||||||
BOX II:194 | 1962-1969 | ||||||||||||
(3 folders) | |||||||||||||
BOX II:195 | circa 1960s | ||||||||||||
Next Page » |